These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 8315480

  • 21. Comparison of normal tissue pharmacokinetics with 111In/90Y monoclonal antibody m170 for breast and prostate cancer.
    Lehmann J, DeNardo GL, Yuan A, Shen S, O'Donnell RT, Richman CM, DeNardo SJ.
    Int J Radiat Oncol Biol Phys; 2006 Nov 15; 66(4):1192-8. PubMed ID: 16965873
    [Abstract] [Full Text] [Related]

  • 22. 111In-labeled EGF is selectively radiotoxic to human breast cancer cells overexpressing EGFR.
    Reilly RM, Kiarash R, Cameron RG, Porlier N, Sandhu J, Hill RP, Vallis K, Hendler A, Gariépy J.
    J Nucl Med; 2000 Mar 15; 41(3):429-38. PubMed ID: 10716315
    [Abstract] [Full Text] [Related]

  • 23. A phase I trial combining high-dose 90Y-labeled humanized anti-CEA monoclonal antibody with doxorubicin and peripheral blood stem cell rescue in advanced medullary thyroid cancer.
    Sharkey RM, Hajjar G, Yeldell D, Brenner A, Burton J, Rubin A, Goldenberg DM.
    J Nucl Med; 2005 Apr 15; 46(4):620-33. PubMed ID: 15809485
    [Abstract] [Full Text] [Related]

  • 24. Reassessment of diethylenetriaminepentaacetic acid (DTPA) as a chelating agent for indium-111 labeling of polypeptides using a newly synthesized monoreactive DTPA derivative.
    Arano Y, Uezono T, Akizawa H, Ono M, Wakisaka K, Nakayama M, Sakahara H, Konishi J, Yokoyama A.
    J Med Chem; 1996 Aug 30; 39(18):3451-60. PubMed ID: 8784442
    [Abstract] [Full Text] [Related]

  • 25. Pretargeting with labeled bivalent peptides allowing the use of four radionuclides: (111)In, (131)I, (99m)Tc, and (188)Re.
    van Schaijk FG, Oosterwijk E, Soede AC, Oyen WJ, McBride WJ, Griffiths GL, Goldenberg DM, Corstens FH, Boerman OC.
    Clin Cancer Res; 2003 Sep 01; 9(10 Pt 2):3880S-5S. PubMed ID: 14506186
    [Abstract] [Full Text] [Related]

  • 26. Radioimmunolocalization of breast cancer using BrE-3 monoclonal antibody.
    Kramer EL, DeNardo SJ, Liebes L, Noz ME, Kroger L, Glenn SD, Furmanski P, Ceriani R.
    Adv Exp Med Biol; 1994 Sep 01; 353():181-92. PubMed ID: 7985537
    [No Abstract] [Full Text] [Related]

  • 27. Pharmacokinetics of indium-111 labeled 10-3D2 antibreast-tumor antibody in patients.
    Hnatowich DJ, Rusckowski M, Siebecker DA, Gionet M, Mardirossian G, Bushe HS, Roy S, Mattis JA, Shealy D, Griffin TW.
    J Nucl Biol Med (1991); 1992 Sep 01; 36(1):7-13. PubMed ID: 1450229
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Pharmacokinetics and scintigraphy of indium-111-DTPA-MOC-31 in small-cell lung carcinoma.
    Kosterink JG, de Jonge MW, Smit EF, Piers DA, Kengen RA, Postmus PE, Shochat D, Groen HJ, The HT, de Leij L.
    J Nucl Med; 1995 Dec 01; 36(12):2356-62. PubMed ID: 8523132
    [Abstract] [Full Text] [Related]

  • 32. [Phase I clinical study for 111In-DTPA-IgG].
    Kubo A, Nakamura K, Hashimoto J, Hashimoto T, Sammiya T, Shimizu S, Shimada K.
    Kaku Igaku; 1994 Sep 01; 31(9):1121-31. PubMed ID: 7967198
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Reduced hepatic accumulation of radiolabeled monoclonal antibodies with indium-111-thioether-poly-L-lysine-DTPA-monoclonal antibody-TP41.2F(ab')2.
    Wang TS, Fawwaz RA, Alderson PO.
    J Nucl Med; 1992 Apr 01; 33(4):570-4. PubMed ID: 1552342
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Pharmacokinetics in patients of an anti-carcinoembryonic antigen antibody radiolabeled with indium-111 using a novel diethylenetriamine pentaacetic acid chelator.
    Hnatowich DJ, Rusckowski M, Brill AB, Siebecker DA, Misra H, Mardirossian G, Bushe H, Rescigno A, Stevens S, Johnson DK.
    Cancer Res; 1990 Nov 15; 50(22):7272-8. PubMed ID: 2224858
    [Abstract] [Full Text] [Related]

  • 38. Radioimmunodetection of medullary thyroid cancer using a bispecific anti-CEA/anti-indium-DTPA antibody and an indium-111-labeled DTPA dimer.
    Peltier P, Curtet C, Chatal JF, Le Doussal JM, Daniel G, Aillet G, Gruaz-Guyon A, Barbet J, Delaage M.
    J Nucl Med; 1993 Aug 15; 34(8):1267-73. PubMed ID: 8326383
    [Abstract] [Full Text] [Related]

  • 39. Breast tumor radioimmunodetection with a 111In-labeled monoclonal antibody (MA5) against a mucin-like antigen.
    Major PP, Dion AS, Williams CJ, Mattes MJ, Wang T, Rosenthall L.
    Cancer Res; 1990 Feb 01; 50(3 Suppl):927s-931s. PubMed ID: 2297743
    [Abstract] [Full Text] [Related]

  • 40. Preclinical studies of indium-111-labeled IgM: a human monoclonal antibody for infection imaging.
    Subramanian R, Vallabhajoshula S, Lipszyc H, Zhao Q, Murray J, Shaban S, Machac J, Hanna MG.
    J Nucl Med; 1997 Jul 01; 38(7):1054-9. PubMed ID: 9225790
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.